1. Home
  2. BNC vs XOMA Comparison

BNC vs XOMA Comparison

Compare BNC & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CEA Industries Inc.

BNC

CEA Industries Inc.

HOLD

Current Price

$2.84

Market Cap

287.3M

Sector

Industrials

ML Signal

HOLD

Logo XOMA Corporation

XOMA

XOMA Corporation

HOLD

Current Price

$30.17

Market Cap

308.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNC
XOMA
Founded
N/A
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
287.3M
308.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNC
XOMA
Price
$2.84
$30.17
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$60.60
AVG Volume (30 Days)
230.7K
99.5K
Earning Date
03-16-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$24.95
Revenue Next Year
N/A
$6.20
P/E Ratio
$0.22
$29.64
Revenue Growth
N/A
N/A
52 Week Low
$2.93
$18.40
52 Week High
$31.62
$39.92

Technical Indicators

Market Signals
Indicator
BNC
XOMA
Relative Strength Index (RSI) 30.66 65.21
Support Level N/A $23.92
Resistance Level $4.14 $30.79
Average True Range (ATR) 0.26 1.49
MACD 0.01 0.32
Stochastic Oscillator 1.16 74.74

Price Performance

Historical Comparison
BNC
XOMA

About BNC CEA Industries Inc.

CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: